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Summary 
The hereditary disease Cockayne syndrome (CS) is 
characterized by a complex clinical phenotype. CS 
cells are abnormally sensitive to ultraviolet radiation 
and are defective in the repair of transcriptionally ac- 
tlve genes. The cloned CSB gene encodes a member 
of a protein family that includes the yeast SnfP protein, 
a component of the transcriptional regulator SwilSnf. 
We report the cloning of the CSA cDNA, which can 
encode a WD repeat protein. Mutations in the cDNA 
have been identified in CS-A cell lines. CSA protein. 
interacts with CSB protein and with p44 protein, a sub- 
unit of the human RNA polymerase II transcription fac- 
tor IIH. These observations suggest that the products 
of the CSA and CSB genes are involved in transcription. 
Introduction 
Cockayne syndrome (CS) is a rare autosomal recessive 
disease characterized primarily by postnatal failure of 
growth and progressive neurological dysfunction (re- 
viewed by Friedberg et al., 1995). A recent comprehensive 
review of the clinical features of 140 cases (Nance and 
Berry, 1992) indicates that growth failure is a cardinal clini- 
cal feature in all cases and generally manifests in the first 
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year of life. Body weight tends to be affected more severely 
than body length, leading to a characteristic appearance 
of so-called cachectic dwarfism. All CS patients develop 
neurological symptoms or signs, of which the most com- 
mon are mental retardation and microcephaly (Nance and 
Berry, 1992). The majority of CS patients also suffer oph- 
thalmic changes, in particular pigmentary degeneration 
of the retina and cataracts. Dental abnormalities are com- 
mon, and about 75% of patients manifest abnormal sensi- 
tivity to sunlight. The mean age of death in 34 cases was 
-12 years, but some patients have survived into their 
teens and twenties (Nance and Berry, 1992). Laboratory 
tests are not diagnostic. However, increased ventricular 
size, cerebral atrophy, or both, as well as calcification of 
the basal ganglia, are frequently observed by computer- 
ized tomography or magnetic resonance imaging of the 
brain. Histopathology of the brain at autopsy typically re- 
veals patchy demyelination of subcortical matter (Nance 
and Berry, 1992). 
The observation of photosensitivity in many cases of 
CS prompted studies of radiation sensitivity at the cellular 
level. Lymphoblastoid and fibroblast cell lines from all 
known CS patients have increased sensitivity to killing by 
ultraviolet (UV) radiation at -254 nm (Schmickel et al., 
1977; Andrews et al., 1978; Hoar and Waghorne, 1978; 
Wade and Chu, 1979; Marshall et al., 1980; Lehmann et 
al., 1993). Conventional measurements of nucleotide exci- 
sion repair, the repair mode primarily involved in the repair 
of DNA damage produced by UV radiation, indicate no 
defect in CS cells (reviewed by Friedberg et al., 1995). 
However, in contrast with normal human cells, which per- 
form nucleotide excision repair of the template (tran- 
scribed) strand of transcriptionally active genes at a faster 
rate than the coding (nontranscribed) strand, CS cells fail 
to show this kinetic difference and are considered to be 
defective in strand-specific repair of transcriptionally ac- 
tive genes (Mullenders et al., 1992; van Hoffen et al., 
1993). This phenotype may also be reflected in the obser- 
vation that CS cells are defective in the reactivation of the 
expression of a plasmid-borne chloramphenicol acetyl- 
transferase (CAT) reporter gene when this gene is inacti- 
vated by irradiation of the plasmid prior to transfection of 
cells (Schweiger et al., 1987; Barrett et al., 1991). 
CS cells in culture suffer a significant delay in the recov- 
ery of bulk DNA and RNA synthesis following exposure 
to UV radiation (Lehmann et al., 1979; Lehmann, 1982; 
Mayne and Lehmann, 1982; Sugita et al., 1987; Lehmann 
et al., 1993). The delayed kinetics of the recovery of RNA 
synthesis have been exploited for complementation analy- 
sis in heterodikaryons derived by fusion of cells from differ- 
ent CS patients. This analysis has defined two genetic 
complementation groups, designated CS-A and CS-B (Ta- 
naka et al., 1981; Lehmann, 1982). A human gene (origi- 
nally called ERCCG) was isolated by correction of the UV 
sensitivity of a Chinese hamster ovary cell line designated 
UV81 (Troelstraet al., 1990). Subsequent studies showed 
that the ERCCG gene corrects the cellular phenotypes of 
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CS-6 cells, but is without effect on the UV sensitivity of 
CS-A cells, or cells from the nucleotide excision repair- 
defective disorder xeroderma pigmentosum (XP) (Troels- 
tra et al., 1992). Sequence analysis of the ERCC6 gene 
from CS-B patients has revealed the presence of muta- 
tions (Troelstra et al., 1992; D. Mallery and A. R. L., unpub- 
lished data). In light of these observations and in keeping 
with recent nomenclatural recommendations (Lehmann et 
al., 1994) the fRCC6 gene is now referred to as CSB. 
The molecular basis of the complex clinical phenotype 
of CS is unknown. Here we report the molecular cloning 
of the human CSA gene by functional complementation of 
CSA cells. A CSA cDNA uniquely and specifically corrects 
UV sensitivity and defective CA Tgene reactivation in CS-A 
cells. Additionally, mutations have been identified in CSA 
cDNAs of all CS-A cell lines examined, including an identi- 
cal mutation in two CS-A siblings. The CSA gene is ex- 
pected to encode a polypeptide of 396 amino acids with 
a calculated molecular mass of -44 kDa. The predicted 
amino acid sequence of the putative CSA protein indicates 
that it is a WD repeat (WD-40 repeat) protein (reviewed 
by Neer et al., 1994). In vitro translated CSA protein specifi- 
cally interacts with CSB protein and with p44 protein, a 
subunit of the RNA polymerase II basal transcription factor 
TFIIH (Drapkin et al., 1994; Roy et al., 1994; Mu et al., 
1995; Aboussekhra et al., 1995). These observations, cou- 
pled with the observation that the amino acid sequence 
of the predicted CSB polypeptide is homologous with a 
component of the yeast Swi/Snf transcriptional activation 
complex, suggest that CS cells may be defective in RNA 
polymerase II transcription. 
Results 
Functional Complementation of CS-A Cells 
A human cDNA library constructed from size-fractionated 
cDNA cloned in an episomal plasmid vector (Legerski and 
Peterson, 1992) was screened for functional complemen- 
tation of the UV radiation-sensitive phenotype of CS-A 
cells. No UV-resistant colonies were obtained after the 
screening of - 400,000 hygromycin-resistant colonies ob- 
tained by electroporation with a fraction enriched for 
cDNAs >4 kb in size. A single UV-resistant colony was 
observed after screening - 200,000 hygromycin-resistant 
colonies with a fraction enriched for cDNA inserts in the 
2-4 kb size range. The UV-resistant clonal line was ex- 
panded, and the plasmids were rescued to Escherichia 
coli. Restriction analysis revealed that all the plasmids 
were identical and contained a cDNA insert of - 2.2 kb. 
This plasmid is designated pCSA5 and was purified for 
further analysis. 
To verify that the increase in resistance to UV radiation 
was effected by a plasmid-borne element rather than by 
mutational reversion in the mass culture caused by expo- 
sure of the cells to UV light, plasmid pCSA5 was retrans- 
fected into CS-A cells. These cells express the Epstein- 
Barr virus (EBV) nuclear antigen 1 (EBNAl) protein. Hence, 
the EBV-based vectors used in these studies replicate au- 
tonomously as episomal plasmids, circumventing the 
need to analyze numerous clonal lines to identify a particu- 
lar line that expresses the cDNA. A population of -2000 
independent transfectants not previously exposed to UV 
light was analyzed for complementation of the UV sensitiv- 
ity of CSA cells. Survival was quantitated by colony-forming 
ability and expressed as a percentage relative to unirradi- 
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Figure 1. Complementation of UV Radiation Sensitivity of CSA Cells, 
But Not CS-B or XP-C Cells, by Plasmid pCSA5 
(A) Survival after exposure to UV radiation of the repair-proficient line 
HT1080 (closed triangles), the CSA line CSA/ENlS (closed circles), 
CM/EN12 cells carrying plasmid pCSA5 (open circles), the CS-B line 
CSBIEN7 (closed squares), and CSBIEN7 carrying pCSA5 (open 
squares). 
(B) Survival after exposure to UV radiation of the repair-proficient line 
HTIOBO (closed triangles), an XP-C line XPClENlP (closed squares), 
XPClENlP cells carrying plasmid pXPC3, which expresses the human 
XPC cDNA (open triangles), and XPClENlP cells carrying pCSA5 
(open squares). 
(C) Survival after exposure to UV radiation of the normal lymphoblas- 
toid line GM1953 (Closed triangles), the CS-A lymphoblastoid line 
GM2964 carrying the vector (closed circles), and GM2964 cells car- 
rying plasmid pCSA5 (open circles). 
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Figure 2. Complementation of CAT Reactivation Ability of CS-A But 
Not CSB Cells by Plasmid pCSA5 
CAT activity is expressed as a percentage of the activity observed 
in irradiated cells versus unirradiated controls. Repair-proficient line 
HTlCtSO (closed triangles); CS-A line CSAIEN12 (closed circles); CSA/ 
EN1 2 ceils carrying plasmid pCSA5 (open circles); CSB line CSB/EN7 
(closed squares); CSB/EN7 cells with plasmid pCSA5 (open squares). 
ated controls. Once again, plasmid pCSA5 conferred en- 
hanced radiation resistance to CS-A cells (Figure 1A). 
In experiments designed to determine the genetic speci- 
ficity of this phenotypic complementation, the plasmid was 
also transfected into CSB cells and cells from XP genetic 
complementation group C (XPC). The latter cells are known 
to be hypersensitive to UV radiation because of a defect 
in nucleotide excision repair (reviewed by Friedberg et 
al., 1995). The plasmid did not enhance the UV radiation 
resistance of either of these cell types, verifying that the 
UV resistance is specific for CS-A cells (Figures 1A and 
1 B). To exclude the possibility that the UV resistance was 
an artifact of the particular cell line used, plasmid pCSA5 
was also electroporated into the CS-A lymphoblastoid cell 
line GM2964 derived from a different CS-A individual. Once 
again, we observed enhanced UV resistance compared 
with that in the presence of the vector alone (Figure 1C). 
This result simultaneously demonstrates that the cloned 
cDNA complements the CS cellular phenotype in both 
lymphoblastoid and fibroblast cell lines. The level of phe- 
notypic correction observed with the lymphoblastoid line 
was not as complete as that observed with SV46-trans- 
formed fibroblasts. This may in part reflect limitations of 
thesurvival procedure used with the lymphoblastoid cells, 
which were grown in suspension culture (see Experimen- 
tal Procedures). 
To confirm that the enhanced resistance to UV radiation 
correlates with an increased capacity for DNA repair, we 
measured the ability of cells to reactivate the expression of 
an inactivated (by exposure to UV radiation) CAT reporter 
gene. CS-A cells carrying plasmid pCSA5 showed signifi- 
cantly enhanced levels of CAT activity compared with 
those in the parental cell line (Figure 2). Transfection of 
CS-B cells with the plasmid did not result in reactivation 
Figure 3. Nucleotide and Predicted Amino Acid Sequence of the CSA 
cDNA 
The cDNA insert of clone pCSA5 was sequenced on both strands. 
The amino acids in core regions of the WD repeat motifs are shown 
in bold. The polyadenylation signal AATAM in the 3’ untranslated 
region is underlined. 
of CATgene expression (Figure 2), once again demonstra- 
ting the genetic specificity of the complementation with 
plasmid pCSA5. 
Sequence Analysis of the CSA cD?4A 
The cDNA insert of clone pCSA5 (designated as the CSA 
cDNA) was sequenced on both strands (Figure 3). The 
first ATG at nucleotide 37 is preceded by G at the -3 
position, where a purine residue has been shown to be 
important for the initiation of translation (Kozak, 1966). An 
open reading frame that could encode a 396 amino acid 
polypeptide terminates at nucleotide position 1224, fol- 
lowed by an extended 3’ untranslated region. The poly(A) 
addition signal AATAAA begins at nucleot& position 1966, 
and a poly(A) tail begins at nucfeotide 2011 (Figure 3). 
The calculated size of the predicted CSA protein is 44 kDa, 
with a calculated isoelectric point of 6.32 as determined by 
the Peptidesort program of Genetics Computer Group. No 
significant matches were found by searching the Gen- 
Bank, EMBL, or dbEST databases wtth the CSA cDNA 
sequence by using the BLASTN program. However, by 
use of the BLASTX program, significant scores were ob- 
served with a number of WD repeat proteins (reviewed by 
Neer et al., 1994) including the Xenopus laevts f3-Trcp 
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protein, the Saccharomyces cerevisiae Tupl protein, the 
human Miller-Dieker lissencephaly protein, and the hu- 
man P-transducin protein. Further analysis of the predicted 
CSA polypeptide sequence revealed the presence of five 
WD repeat motifs (Figure 4). In the first repeat, the consen- 
sus amino acid sequence G/SIAN, H, which marks the 
beginning of the repeated motif, is replaced by I, H (Figure 
4), and in repeat 5, the consensus sequence WIFN, DIN/ 
R/K, which denotes the end of the motif, is replaced by 
W, V (Figure 4). The length of the core between the GH 
and WD sequences in each repeat of the predicted CSA 
protein is 34 or 35 amino acids, consistent with the range 
of 23-41 amino acids observed in other members of this 
class of proteins (reviewed by Neer et al., 1994). Also con- 
sistent with the structure of this class of proteins, two of 
the five repeats (repeats 2 and 3) have no mismatches 
with the consensus core repeat sequence (Figure 4) while 
the remaining three repeats (repeats 1, 4, and 5) each 
have three or fewer mismatches (Figure 4) (reviewed by 
Neer et al., 1994). 
Mutational Analysis of the CSA Gene 
Polymerase chain reaction (PCR) primers were prepared 
that facilitated amplification of the CSA coding region in 
two overlapping segments. The primer pairs used for the 
amplification of the 5’ and 3’ halves of CSA cDNAs were 
designated Ml -M2 and M3-M4, respectively. First-strand 
cDNAspreparedfrom theCS-Aprimaryfibroblastcell lines 
CS5BR and CSGBR, the normal primary human fibroblast 
cell line CCD-42Sk (CRLl513), or HeLa cells were used 
assubstrates in the PCR reaction. Agarose gel electropho- 
resis of the PCR products derived from CS5BR cDNA by 
using the Ml-M2 primer pair showed a single band that 
comigrated with the PCR band derived from HeLa cDNA. 
This band was gel purified and directly sequenced with 
an automated sequencer and was found to be completely 
congruent with the wild-type sequence. Electrophoresis 
of the PCR products derived from the CSSBR cell line by 
using the M3-M4 primer pair revealed two CSA-specific 
bands, both of which migrated faster than the single band 
derived from the normal human fibroblast cetf line or from 
HeLa cells (Figure 5A). The faster-migrating band was gel 
purified and directly sequenced. This analysis revealed 
a 279 bp deletion in the CSA coding region, starting at 
nucleotide position 660 and ending at nucleotide position 
1156 (Figure 58). The slower-migrating CS5BR band was 
contaminated by a nonspecific PCR product. Hence, this 
Figure 4. Alignment of the Conserved Re- 
gions of the WD Repeats in the Predicted CSA 
Protein Sequence 
The WD repeat regions of the CSA sequence 
are aligned by use of published criteria (Neer 
et al., 1994). The regular expression pattern is 
shown at the top of the figure, where X con- 
notes any amino acid, and curly brackets indi- 
cate the range over which that amino acid can 
be repeated. 
band was cloned into the vector pBSII, and two indepen- 
dently isolated clones were sequenced. This analysis 
demonstrated the presence of an identical 61 bp deletion 
in the CSA coding region in both clones, starting at nucleo- 
tide position 1076 and also ending at nucleotide position 
1156 (Figure 58). The same two deletions were identified 
in CSA cDNA isolated from the cell line CSGBR, derived 
from a sibling of the CSSBR individual, but not in two other 
CS-A cell lines examined (data not shown). 
A 1 2 3 4 
B 
Figure 5. Mutational Analysis of the CSA Gene in the Primary Fibro- 
blast Cell Line CS5BR 
(A) PCR products derived from cDNAs by using the M-M4 primer 
pair (see text for details). Lane 1, DNA size markers; lane 2, PCR 
products from CSBBR cells; lane 3, PCR products from CCD-42Sk 
cells (normal diploid human fibroblasts); lane 4, PCR products from 
HeLa cells. 
(8) Schematic representation of deletions identified in CSA cDNAs of 
CSBBR and CSGBR cells. 
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Figure 6. Interaction of CSA with CSB and p44 Proteins 
(A) CSA protein was synthesized and radiolabeled in the presence of 
[YSjmethionine during in vitro translation and precipitated by ammo- 
nium sulfate (lane 1; I, input), or mixed with either in vitro translated 
epitope-tagged CSS protein (lane 2) or epitope-tagged ~44 protein 
(lane 3) and precipitated in the presence of monoclonal antibodies 
to the 9ElO epitope. Control precipitation in the absence of in vitro 
translated protein is shown in lane 4. Equal volumes of the immunopre- 
cipitates were analyzed by SDS-PAGE. 
(8) Similar experiment as described in (A) but using in vitro translated 
epitope-tagged XPS protein (lane 2) XPD protein (lane 3) p62 protein 
(lane 4). and ~44 protein (lane 5). Control without epitope-tagged pro- 
teins is lane 6. 
(C) Identical experiment to that in (A) using two radiolabeled trunca- 
tions of the CSA polypeptide, CSAl-167 (lanes l-4) and CSAI-146 
(lanes 5-6). 
CS5BR and CSGBR are known to be the offspring of a 
consanguineous marriage (A. R. L., unpublished data) and 
are therefore likely to carry the same mutation in both 
allelesof the CSA gene. The observation that the deletions 
identified in both cDNAs from both siblings end at the 
identical nucleotide position (nucleotide 1156) strongly 
suggests that this nucleotide marks an exonlintron junc- 
tion and that the truncated cDNAs represent abnormally 
spliced products missing either one (61 bp) or two (279 
bp) upstream exons. These abnormal splice products pre- 
sumably derive from a homozygous mutation in a splice 
donor site. Neither deletion creates a frame shift. Hence, 
the two abnormal transcripts potentially encode internally 
deleted proteins with predicted sizes of 303 and 369 amino 
acids. 
Mutations were also identified in CSA cDNAs in two 
other CSA primary fibroblast cell lines examined and in 
the lymphoblastoid line GM2964, the UV sensitivity of 
which was shown to be corrected by the CSA cDNA (see 
above). One of these mutations changes codon 322 from 
TAC (encoding tyrosine) to the stop codon TAA. The de- 
tails of this mutational analysis will be presented else- 
where (L. L. et al., unpublished data). On the basis of these 
results, we conclude that the cDNA that complements the 
cellular phenotypes of CS-A cells is derived from the CSA 
gene. 
CSA Protein Interacts with Human CSB Protein 
and with the p44 Subunit of TFIIH 
In light of the possibility that the products of the CSA and 
CSBgenesare involved in the same biochemical or regula- 
tory pathway, or both, we asked whether these polypep- 
tides physically interact. The cloned CSB gene was engi- 
neered to express the 9ElO epitope, which is specifically 
recognized by a monoclonal antibody to the human c-Myc 
protein (see Experimental Procedures). Following the syn- 
thesis of unlabeled epitope-tagged CSB protein and of 
radiolabeled CSA protein by in vitro transcription and 
translation of the cloned CSA and CSB cDNAs, the two 
proteins were observed to coprecipitate in the presence 
of antibody to the epitope (Figure 6A, lane 2). Only back- 
ground levels of precipitated CSA protein were observed 
in the presence of the antibody but in the absence of epi- 
tope-tagged CSB protein (Figure 6A, lane 4). The interac- 
tion between CSA and CSB proteins was confirmed in vivo 
by the use of the two-hybrid genetic system (Chien et al., 
1991). When yeast cells were transformed with a plasmid 
carrying the CSA gene fused to the DNA-binding domain 
in the yeast GAL4 gene, together with one carrying the 
CSB gene fused to the GAL4 activation domain, 16 Miller 
units of 6galactosidase were detected. Transformation 
with either plasmid alone yielded 0.5-l .O units of activity. 
Radiolabeled CSA protein also coprecipitated with epi- 
tope-tagged p44 protein, the 44 kDa subunit of the human 
RNA polymerase II basal transcription factor TFIIH (Drap- 
kin et al., 1994; Roy et al., 1994; Mu et al., 1995; Abous- 
sekhra et al., 1995) (Figure 6A, lane 3). This interaction 
was independently confirmed in other experiments (Figure 
6B, lane 5), in which it was additionally demonstrated that 
CSA protein did not coprecipitate with epitope-tagged ~62, 
xeroderma pigmentosum D (XPD), or XPB proteins, other 
known components of TFIIH (Drapkin et al., 1994; Roy 
et al., 1994; Mu et al., 1995; Aboussekhra et al., 1995) 
(Figure 6B). 
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Figure 7. Mapping of the CSA Gene to Human 
Chromosome 5 
(A) Agarose gel of the PCR amplification prod- 
ucts from DNA in the human/rodent somatic 
cell hybrid panel number 2. The numbers refer 
to chromosomes in the normal human karyo 
type. 
(6) Southern blot hybridization of EcoRI- 
digested DNA from human, mouse, hybrid-A5 
(a mouse/human hybrid containing human 
chromosome 5) and hybrid-Al7 (a mouse/hu- 
man hybrid containing human chromosome 
17) with gel-purified CSA cDNA. 
To define regions of the CSA polypeptide required for 
these interactions, we expressed runoff transcripts and 
translated them in vitro to generate C-terminal deletions 
of the CSA protein. Truncations of the CSA protein car- 
rying just the N-terminal 146 or 167 amino acids (CSA(l- 
146) and CSA(l-167)) both interacted with p44 and CSB 
proteins (Figure 6C). Thus, the N-terminal 146 amino acid 
residues of the CSA protein are apparently sufficient for its 
interactions with both the p44 subunit of theTFllH complex 
and the CSB protein. This region of the polypeptide in- 
cludes the first two of the five WD repeats (see Figure 3). 
Chromosomal Mapping of the CSA Gene 
PCR primers designed to produce human-specific prod- 
ucts from the 3’ untranslated region of the CSA gene were 
used to amplify DNA from the NIGMS human/rodent so- 
matic cell hybrid mapping panel number 2. The 724 bp 
PCR product was identical to that in the CSA cDNA, indi- 
cating that there are no introns in the region of the CSA 
gene amplified. Following electrophoresis, amplification 
products were observed in the human control lanes and 
in the lanes for the chromosome 5 and 6 human/rodent 
somatic cell hybrids (Figure 7A). The chromosome 6 hy- 
brid (GM16629) has been previously reported to give a 
positive signal for the primer set C9, which maps to chro- 
mosome 5~14~12, indicating that this hybrid also carries 
portions of chromosome 5 (Dubois and Naylor, 1993). South 
ern blot hybridization was performed on restictiondigested 
genomic DNA from human, mouse, hybrid-A5 (a mouse/ 
human hybrid containing only human chromosome 5) and 
hybrid-Al7 (a mouse/human hybrid containing human 
chromosome 17) with gel-purified CSA cDNA (Figure 78). 
A hybridizing band of 3.2 kb was detected uniquely in 
human DNA and in the hybrid-A5 DNA, but not in the 
mouse or hybrid-Al 7 DNA (Figure 78). A second 9 kb band 
hybridized to both the mouse and the hybrid-Al7 DNA 
(Figure 78). To confirm the specificity of the 3.2 kb band 
for human DNA, a second Southern blot hybridization was 
performed, using the 724 bp PCR product (nucleotides 
1216-l 942 of the GSA cDNA) as a probe. This exclusively 
yielded the 3.2 kb hybridizing bands in the human and 
hybrid-A5 lanes (data not shown). Additionally, fluorescent 
in situ hybridization to human metaphase preparations us- 
ing biotinylated cDNA as a probe produced a signal exclu- 
sively in the pericentromeric region of human chromo- 
some 5 (data not shown). Collectively, these data localize 
the CSA gene to human chromosome 5. More refined map 
ping of the CSA gene on chromosome 5 will be reported 
elsewhere (L. D. M. et al., unpublished data). 
Discussion 
The increased sensitivity to UV radiation manifested by 
CS cells in culture invited a functional strategy for gene 
cloning. Screening a human expression library in an epi- 
somal-based plasmid yielded a cDNA that corrected the 
UV-sensitive phenotype in both lymphoblastoid and fibro- 
blast lines derived from two different CS-A individuals. This 
cDNA did not complement the UV sensitivity of cells either 
from genetic complementation group B or from an individ- 
ual with the nucleotide excision repair-defective disease 
XP. This specificity, coupled with the reactivation of defec- 
tive expression of a UV-inactivated plasmid-borne reporter 
gene, strongly suggests that the cDNA derives from the 
CSA gene. Direct confirmation of this suggestion stems 
from the demonstration of mutations in three different 
CSA cell lines, and of truncated cDNAs in two other CSA 
lines that likely represent abnormal splice products conse- 
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quent to a splice donor site mutation. The CSA gene maps 
to human chromosome 5 and hence is unlinked to the 
CSB gene, which was previously shown to map to the 
region lOqll.2 (Troelstra et al., 1992). 
Sequencing the CSA cDNA revealed that the gene can 
encode a polypeptide of 44 kDa with the signature features 
of a WD repeat protein. WD repeat proteins are associated 
with multiple and diverse aspects of cellular metabolism, 
including signal transduction, vesicular trafficking, regula- 
tion of cytoskeletal assembly, cell cycle regulation, RNA 
processing, and gene regulation (reviewed by Neer et al., 
1994). In general, their functions appear to be regulatory 
in nature; no WD repeat proteins have been shown to 
have catalytic functions (reviewed by Neer et al., 1994). 
Structural models suggest that WD repeat proteins are 
endowed with the potential for interactions with other pro- 
teins, consistent with the fact that many such proteins are 
components of multiprotein complexes (reviewed by Neer 
et al., 1994). 
The molecular basis for the well-established sensitivity 
of CS cells to UV radiation is not understood. Measure- 
ments of nucleotide excision repair in UV-irradiated cells 
indicate normal repair of base damage in the genome over- 
all. However, both CS-A and CS-6 cells have been shown 
to be defective in the repair of cyclobutane pyrimidine di- 
mers in transcriptionally active genes compared with tran- 
scriptionally silent regions of the genome (Venema et al., 
1990). More refined studies indicate that there is a particu- 
larly pronounced defect in nucleotide excision repair of 
the template (transcribed) strand of transcriptionally active 
genes (Mullenders et al., 1992; van Hoffen et al., 1993). 
These results have fostered the notion that the primary 
defect in CS cells is in the preferential repair of transcrip- 
tionally active genes. This model has been reinforced by 
the observation that the translated amino acid sequences 
of the human CSB (ERCCG) gene and the E. coli mfd gene 
(which is believed to be required for the coupling of nucleo- 
tide excision repair to sites of arrested transcription) both 
contain consensus helicase motifs (reviewed by Selby and 
Sancar, 1994). Hence, it has been suggested that the CSB 
gene product may function as a transcription repair cou- 
pling factor in human cells (reviewed by Selby and Sancar, 
1994). 
It is conceivable that defective repair of transcriptionally 
active genes might alter levels of gene expression. How- 
ever, on the basis of present knowledge, it is difficult to 
imagine how this could selectively affect certain genes, 
thereby resulting in the specific clinical and cellular pheno- 
types of CS. Defective repair of UV radiation-induced 
damage in CS cells is not confined to the template strand 
of transcriptionally active genes. The rate of removal of 
pyrimidine dimers from the coding (nontranscribed) strand 
is also somewhat reduced compared with the rate in nor- 
mal cells (Mullenders et al., 1992; van Hoffen et al., 1993). 
Additionally, defective repair of rRNA genes has been 
observed in CS cells (Christians and Hanawalt, 1994). 
Hence, it is suggested that the CSA and CSB gene prod- 
ucts may play a role in the modulation of chromatin struc- 
ture during general transcription, thereby facilitating repair 
in such genes (Christians and Hanawalt, 1994). 
The notion that the CSA and CSB proteins are involved 
in transcription in as yet unidentified ways is supported 
by several observations. Recent studies have shown that 
the XfD and XPB genes encode polypeptides that are 
subunits of the RNA polymerase II basal transcription fac- 
tor TFIIH (Drapkin et al., 1994; Roy et al., 1994; Mu et al., 
1995; Aboussekhra et al., 1995). These (and other compo- 
nents of TFIIH) are bifunctional proteins that participate 
both in RNA polymerase II transcription initiation and in 
nucleotide excision repair (Drapkin et al., 1994; Roy et al., 
1994; Mu et al., 1995; Aboussekhra et al., 1995). It has 
been suggested that mutations in these proteins may inac- 
tivate their function in nucleotide excision repair, perturb 
their role in RNA polymerase II transcription initiation, or 
both (Bootsma and Hoeijmakers, 1993; Friedberg et al., 
1994; Vermeulen et al., 1994). Hence, a transcription de- 
fect, rather than a defect in DNA repair, may be the primary 
pathogenetic determinant that results in the complex clini- 
cal phenotype of CS associated with mutational inactiva- 
tion of the XPB or XPD genes. 
The observation that the clinical features of CS also 
accompany mutational inactivation of the CSA and CSB 
genes invites speculation that the polypeptides encoded 
by these genes also participate in RNA polymerase II tran- 
scription. Studies in one of our laboratories (that of 
E. C. F.) have demonstrated reduced levels of transcrip- 
tion in vitro from several plasmid-borne RNA polymerase 
II promoters (but not RNA polymerase I or Ill promoters) 
in extracts of lymphoblastoid cells and fibroblasts from all 
CS-A and CS-B individuals examined (G. Dianov et al., 
unpublished data). Similar results have been obtained with 
extracts of XP cells from genetic complementation group 
B(G. Dianovet al., unpublisheddata). Thefurtherobserva- 
tion that the predicted polypeptide product of the CSA 
gene is a WD repeat protein that interacts with the 44 kDa 
subunit of TFIIH is also provocative with regard to a role 
of the CSA gene product in RNA polymerase II transcrip- 
tion. In this regard, it is of interest that the Drosophila 
melanogaster coactivator dTAFI180, which associates with 
the basal transcription factor TFIID, has also been shown 
to be a WD repeat protein (Dynlacht et al., 1993) as has 
the Tupl protein of S. cerevisiae, which is known to re- 
press the transcription of a variety of genes in yeast (Kel- 
eher et al., 1992). 
CSA protein also interacts with CSB protein. The se- 
quence of a region of -500 amino acids located in the 
middle of the 1493 amino acid CSB polypeptide shows 
significant homology with a number of proteins known to 
be involved in the regulation of gene expression, including 
the Snf2 protein of S. cerevisiae, a component of the multi- 
protein SwilSnf transcriptional activation complex (Troels- 
tra et al., 1992). Given the assumption that abnormal basal 
transcription, activated transcription, or both are indeed 
primary defects in CS cells, it is not difficult to imagine 
that such defects might interfere with the efficiency of DNA 
repair that is coupled to transcription, thereby resulting in 
a secondary phenotype of defective repair of transcription- 
ally active genes when cells are exposed to UV radiation. 
The observation that some individuals with the group G 
form of XP also manifest typical clinical features of CS 
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requires that the transcription hypothesis accommoaate 
some role of the XPG gene in transcription. To date, we 
know of no direct evidence that speaks directly for or 
against such a role. However, recent coimmunoprecipita- 
tion studies have demonstrated an interaction between in 
vitro translated XPG and CSB proteins (N. I. and E. C. F., 
unpublished data). Additionally, the yeast homolog of XPG 
protein (Rad2) interacts with Ssll protein, the yeast homo- 
log of human p44 protein, which, as shown in the present 
study, interacts with CSA protein. Finally, it has been sug- 
gested that mutations in XPG protein might alter RNA poly- 
merase II transcription by perturbing an interconversion 
between the form of TFIIH required for RNA polymerase 
II basal transcription and that required for nucleotide exci- 
sion repair (Svejstrup et al., 1995). 
Experimental Procedures 
Ceil Lines, Transfections, and UV Selection 
The SV4Otransformed CS-A fibroblast line CSSBE.S3.Gl was pro- 
vided by L. V. M. (Brumback et al., 1976; Mayne et al., 1966). The 
EBV-transformed iymphobiast line GM2964 is from an atypical case 
of CS with late onset of clinical symptoms and unusually prolonged 
survival; it was obtained from the Human Genetic Mutant Cell Reposi- 
tory (Kennedy et al., 1980; Otsuka et al., 1984). The CS-A fibrobiast 
cell lines CS5BR and CSGBR were identified and characterized by 
A. R. L. and M. S., and the SV40-transformed CS-B cell line CSI- 
AN.S3.G2 was isolated by L. V. M. (Mayne et al., 1966). The normal 
EBV-transformed iymphoblast line GM1953 was from the Human Ge- 
netic Mutant Ceil Repository; HT1060 (CCLIPI) and CCD-42Sk 
(CRL1513) were from the American Type Culture Collection; and the 
XP-C ceil line XP4PA-SV was provided by Dr. A. Sarasin. 
Fibrobiast lines were maintained in Eagle’s minimal essential me- 
dium (MEM) supplemented with lo%-20% fetal bovine serum (FBS), 
2x nonessential amino acids, 2 mM L-giutamine, 100 U/ml penicillin, 
100 U/ml streptomycin sulfate, and 0.25 pg/ml amphotericin B 
(GIBCO). Lymphobiast lines were maintained in RPM1 1640 media 
supplemented with 20% heat-inactivated FBS, 2 mM L-giutamine, 100 
U/ml penicillin, and 100 U/ml streptomycin sulfate (GIBCO). Selection 
for integration of pSV2neo was with 250 pg/ml G416 (GIBCO), and 
selection for episomai vectors carrying the hph gene was with 177 UI 
ml hygromycin B (Caibiochem). 
The SV48transformed fibrobiast lines CS3BE.S3.Gl, CSlANS3.G2, 
and XP4PA-SV were cotransfected with piasmids pSV2neo (Southern 
and Berg, 1962) and pCMVEBNA (Swirski et al., 1992) by calcium 
phosphate coprecipitation. Cional lines showing increased stable 
transfection with piasmid pDR2 (Murphy et al., 1992) were designated 
CSAIENlP, CSB/EN7, and XPCIENIZ, respectively. Transfection with 
episomai piasmids was by eiectroporation. 
To screen for compiementation of CS-A ceils with a human cDNA 
library in an EBV-based vector, 5 x lO”CSAIEN12 ceils/ml in serum- 
free MEM at room temperature were electroporated at 750 V/cm with 
50 pg of the cDNA library and 350 ng of sonicated herring testes DNA 
as carrier, at a capacitance of 800 pF. After a 10 min recovery period, 
cells were plated with 10 ml of growth media containing 250 nglml 
G418. After electroporation (48 hr later), plates were fed with 10 ml 
of growth media containing 177 U/ml hygromycin B to select for the 
presence of the cDNA library and were refed with hygromycin-con- 
taining medium every 2 days. Approximately 4000 hygromycin-resis- 
tant colonies were obtained per eiectroporation. On days 6, 10, and 
14, plates were irradiated with 4 J/m2 UV radiation at a dose rate of 
1 J/m*/s to select for cDNAs that complemented the UV sensitivity of 
CS cells. After eiectroporation (18-21 days), surviving colonies were 
picked, expanded, and tested for resistance to UV light by irradiating 
one of two 60 mm dishes at 4 J/m2. 
UV Radiation Survival 
Survival of fibroblast lines was quantitated by colony-forming ability. 
Dilutions were plated in triplicate and allowed to attach for 6-16 hr. 
Medium was removed, and the plates were irradiated at a dose rate 
of 1 Jlmz/s. Growth medium was replaced. and plates were incubated 
until colonies were visible (- 14 days), with feeding as necessary. 
Plates were fixed and stained with crystal violet, and colony-forming 
ability was determined. The UV sensitivity of iymphobiast cell lines 
was quantitated by postirradiation viability (Ctsuka et al., 1984). Cells 
(2 x 10s) were washed and resuspended in 3 ml of phosphate-buffered 
saline (PBS) and irradiated at a dose rate of 1 J/m2/s in a 35 mm tissue 
culture dish (in triplicate). The cells were transferred to a 25 cm* flask 
containing 12 ml of growth medium. After 3 days, the number of viable 
ceils was determined by trypan blue exclusion. 
CAT Reactivation Assay 
pRSVcat DNA was irradiated at a dose rate of 3.6 J/m2/s. Piasmid 
DNA (10 ng) was eiectroporated with 400 ug of carrier DNA into IOn 
ceils and plated into 10 ml of growth medium (in triplicate). Later (48 hr), 
plates were washed with PBS, and cells were scraped into a microfuge 
tube. Samples were pelleted, resuspended in 0.25 M Tris (pH 7.7) 
and frozen in dry ice-EtOH, followed by thawing at 37OC, three times. 
Debris was pelleted for 5 min at 4°C and the supernatant transferred 
to a new tube. Protein was quantitated by use of Bio-Rad protein re- 
agent. CAT reactions were carried out at 55OC with 20 ng of total 
protein, 0.2 f&i ldeoxy[dichloroacetyi-1-‘Qzhloramphenicol (Amer- 
sham), and 2.8 mglml acetyl coA (Sigma) in 100 nl of 0.25 M Tris (pH 
7.7). Reactions were terminated by extraction with 1 ml of cold ethyl 
acetate. Acetylated products were separated by thin-layer chromatog- 
raphy and quantitated by scintillation counting. 
Plasmid Rescue, Subcloning, and Sequencing 
Episomai piasmids were rescued by alkaline iysis and transformed 
into E. coii DH5a. An Xbai fragment with the cDNA insert and part of 
the polylinker region of pEBS7 (Peterson and Legerski. 1991) was 
subcloned from pCSA5 into a kanamycin-resistant derivative of pUC, 
pBGS19 (Spratf et al., 1986) for sequence analysis. The cDNA insert 
was sequenced on both strands with Sequenase version 2.0 (United 
States Biochemical Corporation). 
RNA isolation and cDNA Synthesis 
Poiy(A)+ RNA was extracted from ceils with a Fast Track Kit (ln- 
vitrogen). First-strand cDNAs were prepared from 0.5 pg of poly(A) 
RNA by priming with oiigo(dT) as described (Peterson and Legerski, 
1991). After first-strand synthesis, cDNAs were recovered by phenol- 
chloroform extraction, precipitated with ethanol, and resuspended in 
50 ml of TE. 
PCR Ampilfication and Sequencing 
First-strand cDNA (10 ~1) was used for PCR amplification by Taq poiy- 
merase (Promega) in buffer supplied by the manufacturer. Final MgCL 
concentration in the reaction was 1.5 mM. Amplification was performed 
for 30 consecutive cycles of 94OC for 15 s, 52°C for 30 s, and 72OC 
for 2.0 min. Two pairs of primers (Ml-M2 and M3-M4) that divided 
the CSA coding region into two overlapping segments were used. The 
sequences of the primers and their positions relative to the A residue 
of the ATG initiation codon, starting with the upstream pair, were as 
follows. Ml, 5”GCCGGTGTGAGGACACGATA-3’, -19 to +l; M2, 5’- 
AGCACl-TGCTGl-TGCCAAGA-3’, 621-602; M3,5’-CTCACATTCTA- 
CAGGGTCACJ’, 536-555; M4, 5’~AAAGTTTCAGCAGAGACAAA-3’9 
1230-l 211. PCR products were purified by agarose gel electrophore- 
sis and sequenced by the dideoxy method on an Applied Biosystems 
Model 373A automated sequencer. 
Piasmid Constructs for in Vitro Transcription 
Plasmid constructs were generated for in vitro expression of TFIIH 
components either with or without the 9ElO epitope tag by using the 
vector pGEM4Z-SE10 as described (Bardwell et al., 1994). This vector 
contains a sequence encoding 10 amino acids representing the 9ElO 
epitope of c-Myc protein, followed by the poiyiinker in the SP6 orienta- 
tion. Cloning in-frame in these sites followed by in vitro transcription 
from the SP6 promoter generated mRNA that was translated to yield 
9ElO epitope-tagged fusion proteins. Cloning in the opposite orienta- 
tion resulted in constructs that produced nontagged mRNA following 
transcription from the T7 promoter. Constructs were verified by restric- 
tion mapping. 
The CSA gene was cloned into vectors for in vitro transcription by 
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PCR with the following primers: 5’-TGGAATTCATGCTGGGGTT- 
IlTGTCCGC3’(CSAforward) and 5”TTGGAATTCTATTCATCCTTC- 
TTCATCACT-3’ (CSA reverse). EcoRl restriction sites for cloning in- 
frame are underlined. Synthesis of nontagged CSA mRNA was from 
the T7 promoter. To transcribe the full-length CSA gene, the construct 
was linearized at the 3’ end beyond the termination codon. Digestion 
of the template using Sspl and Ndel generated runoff transcripts that 
were translated in vitro to yield polypeptides with C-terminal deletions 
CSA(l-187) and CSA(l-146) respectively. - 
In Vitro Transcription and Translation 
In vitro transcription with the Ambion SP6 or T7 mMessage mMachine 
kit and purification of mRNA were as described (Bardwell et al., 1994). 
In vitro translation of purified mRNA using rabbit reticulocyte lysate 
(Novagen) was carried out in the presence of [-Sjmethionine (Amer- 
sham) at 30°C. Translation of epitope-tagged mRNA and control trans- 
lations were performed under identical conditions, except that the reac- 
tions did not contain labeled methionine. All translation products were 
partially purified by ammonium sulfate precipitation as described (Bar- 
dwell et al., 1994) and used for immunoprecipitation. 
lmmunoprecipitation 
lmmunoprecipitation reactions were carried out in buffer A consisting 
of 20 mM Tris (pH 7.5) 75 mM KCI, 5 mM sodium bisulfite, 4 mM 
MgCb, 0.5 mfvt EDTA, 1 mM DTT, 0.1% Tween 20, 12.5% glycerol, 
and the protease inhibitors pepstatin (1 uglml), leupeptin (1 @ml), 
and PMSF (1 mM). lmmunoprecipitation was carried out as described 
(Bardwell et al., 1994). Partially purified in vitro translated proteins 
were resuspended in buffer A at 3 x translation volume. Aliquots (60 
ul) of each of the two interacting proteins were mixed with 60 pl of 
buffer A and incubated at 30°C for 30 min. Reactions were incubated 
in the presence of 9ElO antibody-protein A-agarose complexes for 
1 hr at room temperature on a rocking platform. Protein complexes 
were pelleted and washed at least three times with buffer A. Following 
resuspension and heat denaturation to disrupt complexes, radioactiv- 
ity in aliquots was measured by liquid scintillation counting. Samples 
were also analyzed by SDS-PAGE using equal volumes of test and 
control reactions on 10% or 15% gels, followed by fluorography. Pro- 
tein-protein interactions were evaluated by comparing the amount 
of radioactivity immunoprecipitated by antibody in the presence of 
epitope-tagged protein with that precipitated nonspecifically in the ab- 
sence of epitope-tagged protein. Radioactivity at least 3-fold above 
background was considered positive after multiple independent exper- 
iments 
Protein-Protein Interactions In Vivo 
Interaction of CSA and CSB proteins in vivo was evaluated with the 
yeast two-hybrid system as described (Bardwell et al., 1993). The CSA 
gene was amplified by PCR from pGEM42-CSA by using primer 4216 
(5”GGCCATGGGCATGCTGGGGGTlTlTGTCCGC-3’) containing an 
Ncol site (underlined) and primer 4217 (5’-TTGGTCGACTATTCATCC- 
TTCTTCATCACTSr) containing a Sal1 site (underlined). The amplified 
product was digested with Ncol and Sall and cloned into plasmid pAS1 
(Durfeeet al., 1993). TheCSBgene wasamplified by PCRfrom plasmid 
pGEM42-CSB by using primer 5091 (5’CTCGGGATCCGTATGC 
CAAATGAGGGAATCCCCCAC-37 containing a BamHl site (under- 
lined) and primer 2388(5’-AAGGGATCCTGTTTAGCAGTATTCTGGC- 
TTGAGTTT-3) containing a BamHl site (underlined). The amplified 
product was digested with BamHl and cloned into PACT (Durfee et 
al., 1993). 
Chromosome Mapping 
PCR amplifications were performed in a Perkin-Elmer 9600 thermal 
cycler using AmpliTaq polymerase and the conditions recommended 
by the supplier (Cetus). Sequences for primers were 5’-GAGCAGC- 
AGTGATGAAGAAGG-3’ (forward) and S’-AGGCAGGAllTGGTCA- 
TACC-3’ (reverse). Resulting PCR products were electrophoresed on 
2% agarose gels. Standard methods were employed for the isolation 
of genomic and plasmid DNA. Southern blot hybridization used EcoRI- 
and HinDIll-digested genomic DNA blotted onto Zeta-Probe Genomic 
Tested membrane according to the recommendations of the manufac- 
turer (Bio-Rad). 
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